CHEMOTHERAPY INDUCED HAIR LOSS
Lily
A wearable, portable and comfortable device to prevent hair loss in chemotherapy patients
Interested in participating in or hosting a clinical trial? Be the first to know.
Clinical need
Hair loss is one of the most difficult aspects of cancer treatment. Chemotherapy attacks fast dividing cells, including hair cells, causing rapid hair loss within 2-3 weeks of starting treatment.
Product
A wearable, portable, cap that uses low-level compression therapy. Worn at every treatment session for 3 to 5 hours.
Next steps
Lily is currently entering in-human clinical trials in Europe.
Estimated launch
2024
Pre-clinical
Healthy volunteers
Pilot clinical trial
Pivotal clinical trial
FDA clearance
CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY
Lilac
The world's first comfortable and portable device to prevent peripheral neuropathy
Interested in participating in or hosting a clinical trial? Be the first to know.
Clinical need
CIPN is the loss of sensory and motor function caused by nerve damage associated with chemotherapy. A staggering 68% of all chemotherapy patients experience CIPN.
Product
A wearable glove and sock combination product that minimises drug delivery to the peripheries.
Next steps
Lilac is currently in a pre-clinical trial with healthy volunteers.
Estimated launch
2026
Healthy volunteers
Pre-clinical trial
Pilot clinical trial
Pivotal clinical trial
FDA clearance